Mayaro Virus RT-LAMP Assay for Specific Point-of-Care Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge of accurately differentiating Mayaro virus (MAYV) infections from other mosquito-borne viruses like Chikungunya, Dengue, and Zika, particularly in regions where they are endemic, is compounded by similar clinical symptoms and the need for rapid, specific detection methods at the point-of-care (POC), especially in resource-limited settings.
Innovation Solution
Development of a reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay using MAYV-specific primers and a sample preparation device (SPD) for integrated sample processing and real-time detection, enabling rapid and specific identification of MAYV in various samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional diagnostic methods are used, then general detection capability is maintained, but specificity and ability to differentiate MAYV from other mosquito-borne viruses deteriorates
Solution Approach 1:
The diagnostic approach segments the detection process into two distinct stages: (1) sample preparation and viral RNA extraction, and (2) specific amplification and detection using MAYV-targeted primers. This segmentation allows each stage to be optimized independently, achieving high specificity through targeted primer design while maintaining manageable complexity through standardized workflow separation.
Solution Approach 2:
The patent introduces viral RNA as an intermediary molecule between the clinical sample and the detection system. By extracting and concentrating viral RNA before amplification, the method creates a purified intermediate that enhances detection specificity and reduces background interference from other viral components, enabling accurate differentiation of MAYV from other mosquito-borne viruses.
2Speed
If rapid detection at point-of-care is implemented, then detection speed is improved, but sensitivity and accuracy may deteriorate
Solution Approach 1:
The method incorporates preliminary viral RNA extraction and concentration steps before the amplification reaction. This preliminary action prepares the sample in advance, removing inhibitors and concentrating the target analyte, which enables rapid and accurate detection at the point-of-care while maintaining high sensitivity through optimized extraction protocols.
Solution Approach 2:
The patent optimizes multiple parameters including primer concentration, reaction temperature, cycle number, and RNA extraction efficiency to achieve the desired balance between speed and accuracy. By carefully adjusting these parameters, the system achieves rapid detection without sacrificing sensitivity, allowing MAYV identification within minutes while maintaining high diagnostic accuracy.
3Measurement precision
If highly specific primers are designed, then detection accuracy is improved, but assay development complexity increases
Solution Approach 1:
The patent designs primer sets that can target multiple conserved regions of the MAYV genome, creating a universal detection system that works across different viral strains and variants. This multi-functionality approach maintains high detection accuracy while simplifying assay development, as the same primer set can be used for various MAYV isolates without requiring strain-specific customization.
Solution Approach 2:
The method uses synthetic viral RNA copies as templates for amplification, created through in vitro transcription from cDNA. This copying approach allows the use of well-characterized reference sequences for primer design while maintaining the ability to detect actual viral infections, thereby achieving high accuracy without the complexity of working directly with live virus or requiring extensive strain-specific characterization.
4Loss of time
If minimal sample preparation is performed, then processing time is reduced, but detection reliability deteriorates
Solution Approach 1:
The patent extracts and concentrates viral RNA from the clinical sample as a separate preparatory step before amplification. This extraction process removes inhibitors and concentrates the target analyte, significantly improving detection reliability. The method maintains minimal preparation time by using rapid extraction protocols and pre-packaged reagents that can be processed within minutes, achieving both speed and reliability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The RT-LAMP assay demonstrates high sensitivity and specificity, allowing for quantitative detection of MAYV at the POC, reducing false negatives and requiring minimal sample preparation time, suitable for resource-limited regions.
Implementation Method 1
reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay
Implementation Method 2
loop-mediated isothermal amplification (LAMP)
Data Source
AI summary
The present disclosure provide for methods of detecting Mayaro virus in a sample, assays for the detection of the Mayaro virus, and Mayaro virus-specific primers. An assay of the present disclosure can include Mayaro virus (MAYV)-specific primers, such as a MAYV-specific forward inner primer, a MAYV-specific backward inner primer, a MAYV-specific forward primer, and a MAYV-specific backward primer. A method provided in the present disclosure of detecting MAYV in a sample can include adding an amount of the sample to a reaction mixture and amplifying the RNA in the sample using reverse transcription loop-mediated isothermal amplification.